Skip to main content

Edris Badreddin

In the past year, 1 open-market sale filing worth $3.40M and no purchases.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
$3.40M
1 filing
Net
−$3.40M
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Edris Badreddin as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

EWTX Edgewise Therapeutics, Inc.

Director1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jan 23, 2026 (view filing)1:34 PM ETJan 212 daysEdris BadreddinDirectorSSale−115.5K$29.44−$3.40M−85.4%19.8K after5 lots10b5-1

SWTX SpringWorks Therapeutics, Inc.

Chief Operating Officer6 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Mar 5, 2025 (view filing)Mar 32 daysEdris BadreddinChief Operating OfficerSSale−20.0K$54.23−$1.08M−10.5%169.7K after4 lots10b5-1
Feb 12, 2025 (view filing)Feb 102 daysEdris BadreddinChief Operating OfficerSSale−30.0K$53.13−$1.59M−13.7%189.7K after10b5-1
Dec 5, 2024 (view filing)Dec 32 daysEdris BadreddinChief Operating OfficerSSale−20.0K$41.96−$839.3K−8.7%209.6K after2 lots10b5-1
Sep 4, 2024 (view filing)Sep 31 dayEdris BadreddinChief Operating OfficerSSale−20.0K$40.65−$812.9K−8.0%229.6K after3 lots10b5-1
Jun 5, 2024 (view filing)Jun 32 daysEdris BadreddinChief Operating OfficerSSale−20.0K$40.07−$801.4K−7.4%249.6K after4 lots10b5-1
Jul 1, 2021 (view filing)Jul 1Same dayEdris BadreddinChief Operating OfficerSSale−32.0K$85.35−$2.73M−9.6%301.5K after